Keegy United States

You are in Choose your city Change
Choose your region and city

* Weather information available.

Search
02 Dec

Phase 3 trial results of LEVADEX orally inhaled migraine therapy to be presented

MAP Pharmaceuticals, Inc. announced today that it will present analysis of data from the efficacy portion of the first Phase 3 trial of its novel LEVADEX orally inhaled migraine therapy, currently in development, at the 14th Congress of the International Headache Society. ...

Bury News-Med...ews Feed September 11


Get Keegy on your site

Put Keegy everywhere

Add buttons to know your online users , ranking position o your visitors vote your stories.